GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: CHI-621 | L04AC02 | SDZ-CHI-621 | Simulect®
basiliximab is an approved drug (FDA (1998), EMA (1998))
Compound class:
Antibody
Comment: Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
View more information in the IUPHAR Pharmacology Education Project: basiliximab |
Classification ![]() |
|
| Compound class | Antibody |
| Approved drug? | Yes. EU EMA (1998) | US FDA (1998) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7578 | basiliximab |
Synonyms ![]() |
| CHI-621 | L04AC02 | SDZ-CHI-621 | Simulect® |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 148 |
| Other databases | |
| GtoPdb PubChem SID | 178103461 |
| PubChem SID | 178103461 |
| Search PubMed clinical trials | basiliximab |
| Search PubMed titles | basiliximab |
| Search PubMed titles/abstracts | basiliximab |
| Wikipedia | Basiliximab |